Genomic Health (GHDX) – Major News
-
Exact Sciences (EXAS) to combine with Genomic Health (GHDX) for $72/share in cash and stock transaction valued at $2.8 billion
-
Exact Sciences (EXAS) Said in Talks to Buy Genomic Health (GHDX) - Bloomberg
-
Genomic Health (GHDX) Tops Q1 EPS by 6c
-
Genomic Health (GHDX) Q4 Revenue Tops Views, Offers Guidance
-
Genomic Health (GHDX) Tops Q3 EPS by 25c, Raises FY Guidance
-
Genomic Health (GHDX) Tops Q2 EPS by 17c
-
Genomic Health (GHDX) Tops Q1 EPS by 11c
-
Genomic Health (GHDX) Misses Q4 EPS by 2c, Slight Miss on Revenues; Offers FY18 EPS Mid-Point Guidance Above Consensus, FY18 Revenue Outlook Below Consensus
-
Genomic Health (GHDX) Said to Explore Options Including Sale Amid Takeover Interest - Bloomberg
-
Genomic Health (GHDX) Tops Q3 EPS by 8c
-
Genomic Health (GHDX) Misses Q2 EPS by 2c
-
Genomic Health (GHDX) Tops Q1 EPS by 5c
-
Genomic Health (GHDX) Tops Q4 EPS by 5c, Offers Guidance
-
Genomic Health (GHDX) Tops Q3 EPS by 1c
-
Genomic Health (GHDX) Reports In-Line Q2 EPS
-
Genomic Health (GHDX) Tops Q1 EPS by 5c
-
Genomic Health (GHDX) Misses Q4 EPS by 1c
-
Genomic Health (GHDX) Prelim. Q4, FY15 Revenues Miss Expectations
-
Genomic Health (GHDX) Reports Q3 Loss Per Share of 36c
-
Genomic Health (GHDX) Misses Q2 EPS by 2c
-
Genomic Health (GHDX) Misses Q1 EPS by 4c
-
Genomic Health (GHDX) Tops Q4 EPS by 2c, FY15 EPS Misses Consensus
-
Genomic Health (GHDX) Tops Q3 EPS by 2c
-
Genomic Health, Inc. (GHDX) Misses Q1 EPS by 6c
-
Genomic Health, Inc. (GHDX) Reports Q4 loss of 30c, Offers Guidance
-
Genomic Health, Inc. (GHDX) Tops Q3 EPS by 6c
-
Genomic Health, Inc. (GHDX) Misses Q2 EPS by 2c
-
Genomic Health, Inc. (GHDX) Reports In-Line Q1 EPS
-
Genomic Health, Inc. (GHDX) Tops Q4 EPS by 3c, Guides FY13
-
Genomic Health, Inc. (GHDX ) Tops Q3 EPS by 6c
-
Genomic Health, Inc. (GHDX) Tops Q2 EPS by 8cm, Offers Q3 Rev. Guidance
-
Genomic Health, Inc. (GHDX) Tops Q1 EPS by 5c
-
Genomic Health, Inc. (GHDX) Misses Q4 EPS by 2c, Offers FY12 Sales Guidance
-
Genomic Health, Inc. (GHDX) Tops Q3 EPS by 6c, Sales Fall Inline
-
Genomic Health, Inc. (GHDX) Tops Q2 EPS by 6c
-
Genomic Health Inc. (GHDX) Misses Q1 EPS by 3c
-
Genomic Health (GHDX) Posts Better-Than-Expected Q3 Results
-
Genomic Health (GHDX) Reports Q4 Loss of $0.01, Beats by 5c; Guides FY10 Sales
-
Genomic Health (GHDX) Tops Q3 EPS by 7c
-
Genomic Health (GHDX) Misses By A Penny
-
Genomic Health (GHDX) Beats The Q1 View By A Penny
-
Genomic Health (GHDX) Tops Q4 View By 3c; Issues Upside Guidance
-
Genomic Health (GHDX) Reports Q3 Loss of $0.11, Beats by 4c
-
Genomic Health (GHDX) Reports Q2 Loss of $0.15, Tops Street by 3c
-
Genomic Health (GHDX) Reports A Q1 Loss of 24c
-
Genomic Health (GHDX) Beats the Street By 3 Cents
-
Genomic Health (GHDX) Announces Collaboration with Pfizer
Back to GHDX Stock Lookup